← Back to catalogue

Anti-β2-GP1 IgG CLIA Microparticles

EUDAMED

Class C (EU MDR)

Ref CMQ3110Model AutoLumo analyzerRef CMQ3103

by Autobio Diagnostics Co., Ltd.

Identity

Trade Name
Anti-β2-GP1 IgG CLIA Microparticles EUDAMED
Model / Reference
AutoLumo analyzer EUDAMED
CMQ3110 EUDAMED
CMQ3103 EUDAMED

Identifiers

Primary DI / UDI-DI
06942359514248 EUDAMED
06942359546669 EUDAMED
Basic UDI-DI
697015090000323HB EUDAMED
EMDN Code
W0102100503 ANTI-B2-GLYCOPROTEIN I ANTIBODIES EUDAMED

Classification

Device Class
Class C EUDAMED
Market of Registration
Italy EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

Yes

EUDAMED

Animal Tissues

Yes

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Anti-β2-GP1 IgG CLIA Microparticles by Autobio Diagnostics Co., Ltd. — Class C — IVDR — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000003348
Authorised Representative
QbD RepS BV BE-AR-000000040

Sources (2)

  • EUDAMED 9b30ed0d-8eb3-4b38-bb66-776bced731bc 61 fields · synced Jul 31, 2026
  • EUDAMED ad5cd49b-53e4-49e5-90be-b8f3e54d7dfa 61 fields · synced May 18, 2026